Literature DB >> 8087914

Intravenous infusion anaesthesia and delivery devices.

D R Miller1.   

Abstract

During the past decade, major advances have taken place with regard to intravenous infusion anaesthesia. New opioid analgesics, iv anaesthetics, and muscle relaxants have become available, which are characterized by a rapid onset of action, short duration of clinical effect, and favourable side effect profiles. Optimal administration of these drugs is often best achieved by continuous infusion, rather than a more traditional technique of intermittent bolus administration. New concepts in pharmacokinetic modelling also provide an enhanced appreciation of the factors which determine rates of recovery upon discontinuation of an intravenous infusion. Pharmacokinetic principles guide rational selection of the iv anaesthetic drugs according to both procedure and patient-specific requirements. In addition, improvements in the new programmable syringe infusion pumps provide a degree of simplicity and accuracy in operation, which make iv infusion of one, two or three components of the anaesthetic state a simple and practical reality for most procedures. In this CME article, these issues will be reviewed according to the following outline: Historical considerations; Rationale for continuous infusion of iv anaesthetic drugs; Pharmacokinetic and pharmacodynamic considerations; Infusion schemes; New techniques, new indications; IV anaesthetic delivery systems; Pharmacoeconomic considerations; Conclusions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087914     DOI: 10.1007/BF03010006

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  12 in total

1.  Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs.

Authors:  M A Hughes; P S Glass; J R Jacobs
Journal:  Anesthesiology       Date:  1992-03       Impact factor: 7.892

2.  Morphine "anesthesia"--a perspective.

Authors:  E Lowenstein
Journal:  Anesthesiology       Date:  1971-12       Impact factor: 7.892

3.  Anaesthesia pharmacoeconomics.

Authors:  D R Bevan
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

4.  Pharmacokinetic model-driven infusion of fentanyl: assessment of accuracy.

Authors:  P S Glass; J R Jacobs; L R Smith; B Ginsberg; T J Quill; S A Bai; J G Reves
Journal:  Anesthesiology       Date:  1990-12       Impact factor: 7.892

5.  Cumulation and reversal with prolonged infusions of atracurium and vecuronium.

Authors:  R J Martineau; B St-Jean; J B Kitts; M C Curran; P Lindsay; K A Hull; D R Miller
Journal:  Can J Anaesth       Date:  1992-09       Impact factor: 5.063

6.  Use of continuous infusion versus intermittent bolus administration of fentanyl or ketamine during outpatient anesthesia.

Authors:  P F White
Journal:  Anesthesiology       Date:  1983-10       Impact factor: 7.892

7.  The differential cost of anesthesia and recovery with propofol-nitrous oxide anesthesia versus thiopental sodium-isoflurane-nitrous oxide anesthesia.

Authors:  Y F Sung; N Reiss; T Tillette
Journal:  J Clin Anesth       Date:  1991 Sep-Oct       Impact factor: 9.452

8.  Hemodynamic and pharmacodynamic comparison of doxacurium and pipecuronium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost?

Authors:  J P Rathmell; R F Brooker; R C Prielipp; J F Butterworth; G P Gravlee
Journal:  Anesth Analg       Date:  1993-03       Impact factor: 5.108

9.  Pharmacokinetics, pharmacodynamics, and rational opioid selection.

Authors:  S L Shafer; J R Varvel
Journal:  Anesthesiology       Date:  1991-01       Impact factor: 7.892

10.  EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil.

Authors:  J C Scott; K V Ponganis; D R Stanski
Journal:  Anesthesiology       Date:  1985-03       Impact factor: 7.892

View more
  3 in total

Review 1.  Intravenous anaesthesia: new drugs, new concepts, and clinical applications.

Authors:  D R Miller
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

2.  Estimation of pharmacokinetic model parameters.

Authors:  A Timcenko; D L Reich; G Trunfio
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1995

3.  A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience.

Authors:  Andrew R Gallimore; Rick J Strassman
Journal:  Front Pharmacol       Date:  2016-07-14       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.